EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Functional CB1 and CB2 Receptors at Pallido-Nigral GABAergic Terminals—Activation by Endocannabinoids

Cecilia Sarai Castillo-Chávez, José Arturo Avalos-Fuentes, Fanny Rodríguez-Cruz, Francisco Javier Paz-Bermúdez, Rodolfo Sánchez-Zavaleta, Francisco García Sierra, Erick Escartín Pérez, Israel Conde Rojas, Benjamín Florán

Cells · 14.11.2026 · 15 (22) · 2081

DOI: 10.3390/cells15222081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 14.11.2026. Verfasst von Cecilia Sarai Castillo-Chávez und 8 weiteren Autor:innen. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CINVESTAV.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CB1 and CB2 receptors form a heteromer expressed in primate pallidal neurons. However, the presence and function of the receptors in rat globus pallidus neurons and their terminals remain unknown. We investigate the presence of CB1 and CB2 receptors on parvalbumin-positive neurons and their function in pallido-nigral terminals, and whether endocannabinoids can activate them. We detected mRNA for CB1 and CB2 receptors in pallidal neurons, and proteins co-expressed in PVA+ neurons. By PLA assay we found proximity of CB1 and CB2 proteins in the globus pallidus and substantia nigra reticulata. Both receptors co-precipitate in the nigral synaptosomes, whereas a pallidal kainic acid lesion decreases coprecipitation. Electrophysiological recordings of pallidal-nigral evoked IPSC GABAergic currents show that selective CB1r activation decreases GABA release, as indicated by a decrement in IPSC amplitude and a change in the paired-pulse ratio. In contrast, activation of CB2r did not modify release. Moreover, CB2r activation decreases the inhibition produced by CB1r. Depolarization suppression of inhibition (DSI) experiments confirmed the activation of CB1 and CB2Rs by endogenous endocannabinoids and the interaction whereby CB2r modulates the effect of CB1r inhibition. These data indicate interacting presynaptic CB1/CB2 receptors at pallido-nigral terminals, which are activated by endocannabinoids and control GABA release, probably reflecting the proposed heteromeric interaction.

Förderung

  • CINVESTAV

Zitieren

APA

Castillo-Chávez, C. S., Avalos-Fuentes, J. A., Rodríguez-Cruz, F., Paz-Bermúdez, F. J., Sánchez-Zavaleta, R., Sierra, F. G., Pérez, E. E., Rojas, I. C., & Florán, B. (2026). Functional CB1 and CB2 Receptors at Pallido-Nigral GABAergic Terminals—Activation by Endocannabinoids. Cells, 15(22), 2081. https://doi.org/10.3390/cells15222081

Vancouver

Castillo-Chávez CS, Avalos-Fuentes JA, Rodríguez-Cruz F, Paz-Bermúdez FJ, Sánchez-Zavaleta R, Sierra FG, et al. Functional CB1 and CB2 Receptors at Pallido-Nigral GABAergic Terminals—Activation by Endocannabinoids. Cells. 2026;15(22):2081. doi:10.3390/cells15222081

BibTeX
@article{CastilloChvez2026,
  author = {Castillo-Chávez, Cecilia Sarai and Avalos-Fuentes, José Arturo and Rodríguez-Cruz, Fanny and Paz-Bermúdez, Francisco Javier and Sánchez-Zavaleta, Rodolfo and Sierra, Francisco García and Pérez, Erick Escartín and Rojas, Israel Conde and Florán, Benjamín},
  title = {Functional CB1 and CB2 Receptors at Pallido-Nigral GABAergic Terminals—Activation by Endocannabinoids},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {22},
  pages = {2081},
  doi = {10.3390/cells15222081}
}
Kostenlos starten →